glp 1 companies to invest in Investment Thesis 3 High Growth GLP-1 Biotech
Description
March 15, 2001
Why It Matters Additional randomized, controlled trials that follow people over time are needed to confirm these findings, but these results are promising, since people with diabetes are at increased risk for developing epilepsy later in life, said study author Edy Kornelius, MD, PhD, of Chung Shan Medical University in Taichung, Taiwan
With the approval of these indications, there will be impacts," comments the Esade professor
Other studies are under way for addiction to alcohol, nicotine, and opioids
However, supplements are adjuncts to, not replacements for, proper nutrition, exercise, and monitoring
The pharmacological profile of GLP-1 agonists extends beyond diabetes management
